29.65  0.59 (2.03%)		05-04 16:00
Open: 29.02 High: 30.4999 Volume: 171,065		Pre. Close: 29.06 Low: 29.02 Market Cap: 557(M)

Short term
Mid term
Targets	6-month :	37.69	1-year :	44.02
Resists	First :	32.27	Second :	37.69
Pivot price	28.69
Supports	First :	28.77	Second :	26.61
MAs	MA(5) :	28.19	MA(20) :	29.06
	MA(100) :	24.93	MA(250) :	21.99
MACD	MACD :	-0.3	Signal :	-0.2
%K %D	K(14,3) :	46.8	D(3) :	30.8
RSI	RSI(14): 54.1
52-week	High :	36.02	Low :	14.39

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TECX ] has closed below upper band by 23.2%. Bollinger Bands are 42.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	30.55 - 30.67	30.67 - 30.8
Low:	28.73 - 28.85	28.85 - 28.98
Close:	29.44 - 29.66	29.66 - 29.89

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Mon, 04 May 2026
MSN Money - MSN

Sun, 03 May 2026
MSN Money - MSN

Fri, 01 May 2026
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Wed, 29 Apr 2026
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Fri, 24 Apr 2026
[ARS] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan

Thu, 23 Apr 2026
Veteran banker Jessica Chutter joins Tectonic (NASDAQ: TECX) board - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	19 (M)
Shares Float	11 (M)
Held by Insiders	39.3 (%)
Held by Institutions	79.9 (%)
Shares Short	2,430 (K)
Shares Short P.Month	2,790 (K)

EPS	-4.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	13.4
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-25.4 %
Return on Equity (ttm)	-37.9 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-4.39
Qtrly Earnings Growth	0 %
Operating Cash Flow	-60 (M)
Levered Free Cash Flow	-39 (M)

PE Ratio	-7.33
PEG Ratio	0
Price to Book value	2.21
Price to Sales	0
Price to Cash Flow	-9.31

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.